H

Haemonetics Corp
D

HAE

76.910
USD
0.60
(0.79%)
مغلق
حجم التداول
5,209
الربح لكل سهم
4
العائد الربحي
-
P/E
23
حجم السوق
3,694,850,845
أصول ذات صلة
ABT
ABT
0.210
(0.16%)
134.280 USD
BDX
BDX
-0.560
(-0.32%)
176.660 USD
EW
EW
-0.480
(-0.62%)
76.540 USD
ISRG
ISRG
3.16
(0.58%)
543.88 USD
MDT
MDT
-0.114
(-0.13%)
88.220 USD
SYK
SYK
-5.11
(-1.30%)
386.66 USD
TMO
TMO
1.69
(0.40%)
429.33 USD
المزيد
الأخبار المقالات

العنوان: Haemonetics Corp

القطاع: Healthcare
الصناعة: Medical Devices
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.